Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics: the Rx perspective.

G Renegar1, P Rieser, P Manasco

  • 1GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.

Expert Review of Molecular Diagnostics
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matter-wave interference of a native polypeptide.

Nature communications·2020
Same author

Resistance of cell membranes to internal pressures.

The Biological bulletin·2010
Same author

Family consent and the pursuit of better medicines through genetic research.

The Journal of continuing education in the health professions·2002
Same author

Applications of pharmacogenetics to drug development: the Glaxo Wellcome experience.

Drug metabolism reviews·2001
Same author

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.

Neurology·1999
Same author

Lamictal (lamotrigine) monotherapy for typical absence seizures in children.

Epilepsia·1999
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
Same journal

Diagnostics and novel laboratory approaches to combat <i>Neisseria gonorrhoeae</i> antimicrobial resistance.

Expert review of molecular diagnostics·2026
Same journal

Fluid biomarkers in cerebral amyloid angiopathy: current limitations and future directions.

Expert review of molecular diagnostics·2026
See all related articles

Pharmacogenetics research offers predictive tools to personalize medicine, minimizing adverse drug reactions and treatment failures. This approach ensures patients receive the most effective drug prescriptions for better health outcomes.

Area of Science:

  • Pharmacology
  • Genetics
  • Personalized Medicine

Background:

  • Pharmacogenetics is revolutionizing drug discovery, development, and patient treatment.
  • Current prescribing practices often lead to adverse drug reactions and treatment failures.
  • Personalized medicine aims to optimize drug efficacy and safety.

Purpose of the Study:

  • To present the 'prescription' perspective of pharmacogenetics.
  • To highlight how pharmacogenetic research can guide optimal drug selection for individual patients.
  • To discuss the broader implications and challenges of implementing pharmacogenetics in clinical practice.

Main Methods:

  • Review of current pharmacogenetic research findings.
  • Analysis of clinical applications and drug development impacts.

Related Experiment Videos

  • Discussion of ethical, legal, and social issues.

    • Main Results:

    • Pharmacogenetic research provides predictive tools for personalized prescribing.
    • Implementation can minimize risks of adverse drug reactions and treatment failures.
    • International collaboration is crucial for advancing the field.

    Conclusions:

    • Pharmacogenetics enables precision prescribing for improved patient outcomes.
    • Addressing challenges in research, application, and ethics is essential.
    • The establishment of a Pharmacogenetics Working Group signifies global commitment.